Adcentrx Therapeutics ("Adcentrx"), a biotechnology company revolutionizing Antibody-Drug Conjugate (ADC) therapeutics for cancer and other life-threatening diseases, announced that China National Medical Products Administration (NMPA) has cleared...
EG-70 program as we look to expand its potential use across bladder cancer." About enGene: enGene is a clinical-stage biotechnology company mainstreaming genetic medicines through the delivery of therapeutics to mucosal tissues and other organs,...
cellular phagocytosis and antibody-dependent cellular cytotoxicity. About Genmab: Genmab is an international biotechnology company with a core purpose guiding its unstoppable team to strive towards improving the lives of patients through innovative...
Onconic Therapeutics, a leading biotechnology company in Korea, announced that the Ministry of Food and Drug Safety (MFDS) of Korea has approved JAQBO (zastaprazan citrate) for the treatment of erosive gastroesophageal reflux disease (GERD) in...
Cresilon Inc. a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, announced it has entered into distribution agreements for VETIGEL® to be sold through several leading regional distributors of veterinary...
Factor Bioscience Inc., a Cambridge-based biotechnology company focused on developing mRNA and cell-engineering technologies, announced its participation in the American Society of Gene & Cell Therapy. Factor will deliver seven presentations,...
the potential to change the way we treat bladder cancer.” About ImmunityBio: ImmunityBio is a vertically-integrated biotechnology company developing next-generation therapies and vaccines that bolster the natural immune system to defeat cancers and...
Can-Fite BioPharma Ltd. a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, announced that Biomedicines published an article titled “Namodenoson at the Crossroad of...
Nested Therapeutics, a biotechnology company pioneering a next-generation precision medicine platform to address hard-to-treat cancers, today announced that the U.S. Food and Drug Administration (FDA) cleared the investigational new drug (IND)....
Multiplex Rapid Test, or to inquire about distribution opportunities, visit CorDx.com. About CorDx: CorDx, a global biotechnology organization, is transforming the global diagnostics industry with innovative R&D solutions, a vertically integrated...
Psilera, a leading biotechnology company developing groundbreaking therapies for hard-to-treat neurological disorders, is pleased to announce the appointment of Magali Haas, M.D., Ph.D., to its esteemed Board of Directors. Dr. Haas brings a wealth...
eClinical platform was designed by clinical professionals for clinical professionals. It is used by pharmaceutical, biotechnology, medical device, and CRO companies to streamline product development lifecycles in a secure, 21 CFR Part 11-compliant...
Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address oncogenic and immune dysregulation that drive cancer, announced three poster presentations at the 2024...
Ginkgo has acquired over a dozen companies and has deep strategic partnerships with many others in the broader biotechnology ecosystem. As such, Ginkgo is uniquely experienced as a systems integrator, offering customers a robust set of services...
Cartridges has been named a finalist in the 2024 Edison™ Awards. The company was honored in the health, medical, and biotechnology category for its Quantra Hemostasis System. The Quantra System with QPlus and QStat Cartridges provides comprehensive...
microbiome health, gut-brain health, and healthy metabolism. From discovery to scale, the company applies science, biotechnology, and intentional development to deliver probiotics, postbiotics, and synbiotics for the business-to-business functional...
models to impact drug development at every stage. About Viscient Biosciences: Viscient Biosciences is an early-stage biotechnology company that is developing novel therapies for MASH and other liver diseases. Its lead compound, built to a novel...
innovation, and collaboration. Explore Pharmaceutical Era today and unlock a world of possibilities in the realm of biotechnology and pharmaceuticals. For media inquiries, partnership opportunities, or general inquiries, please contact us at...
